|
|
Volumn 8, Issue 12, 1999, Pages 2141-2158
|
|
The therapeutic potential of iron chelators
|
|
Author keywords
2 pyridylcarboxaldehyde isonicotinoyl hydrazone; AIDS; Anthracyclines; Chelators; Deferiprone; Desferrioxamine; Friedreich's ataxia; Iron; Iron chelators; Iron overload disease; Malaria; Pyridoxal isonicotinoyl hydrazone; thalassaemia
|
|
Indexed keywords
2 HYDROXY 1 NAPHTHYLALDEHYDE;
ANTHRACYCLINE;
DEFERASIROX;
DEFERIPRONE;
DEFEROXAMINE;
IRON CHELATING AGENT;
PYRIDOXAL BENZOYLHYDRAZONE;
PYRIDOXAL ISONICOTINOYLHYDRAZONE;
RAZOXANE;
SALICYLALDEHYDE BENZOYLHYDRAZONE;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BETA THALASSEMIA;
CANCER;
CANCER CELL;
CARDIOTOXICITY;
CLINICAL TRIAL;
DEGENERATIVE DISEASE;
DRUG STRUCTURE;
FRIEDREICH ATAXIA;
HUMAN;
IRON METABOLISM;
IRON TRANSPORT;
MALARIA;
META ANALYSIS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
REVIEW;
STRUCTURE ACTIVITY RELATION;
SUBCUTANEOUS DRUG ADMINISTRATION;
|
|
EID: 0032746172
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.12.2141 Document Type: Review |
|
Times cited : (38)
|
|
References (159)
|
